Arnulf Stenzl
Active 1990–2025
- 178
- Papers
- 23,147
- Citations
- 85
- h-index
- 165
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine70.1%
- Biochemistry, Genetics and Molecular Biology16.4%
- Immunology and Microbiology8%
- Engineering2.4%
- Computer Science0.8%
- Psychology0.6%
- Other1.7%
Topics
- Bladder and Urothelial Cancer Treatments9.6%
- Prostate Cancer Treatment and Research7.1%
- Prostate Cancer Diagnosis and Treatment6%
- Urinary and Genital Oncology Studies5%
- Immunotherapy and Immune Responses3.7%
- Cancer Immunotherapy and Biomarkers3.4%
- Other65.2%
Coauthors
- Jörg Hennenlotter29
- Jens Bedke26
- Steffen Rausch18
- Andrew J. Armstrong14
- Bastian Amend14
- Karl‐Dietrich Sievert13
- Stephan Kruck12
- Taro Iguchi12
- Arnauld Villers11
- Arun Azad11
- Axel S. Merseburger11
- B. Yа. Alekseev11
- Russell Z. Szmulewitz11
- Antonio Alcaraz10
- Brad Rosbrook10
- Neal D. Shore10
- Viktoria Stühler10
- Daniel P. Petrylak9
- Georg Bartsch9
- Hans‐Georg Rammensee9
- J. Alfred Witjes9
- Jeffrey M. Holzbeierlein9
- Wilhelm K. Aicher9
- Gabriel P. Haas8
All papers
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Authors: Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, B. Yа. Alekseev, Taro Iguchi, Neal D. Shore, Brad Rosbrook, Jennifer Sugg, Benoît Baron, Lucy Chen, Arnulf Stenzl - Journal of Clinical Oncology 2019 cited by 1,186
- Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Authors: Éva Compérat, Mahul B. Amin, Richard Cathomas, Ananya Choudhury, Maria De Santis, Ashish M. Kamat, Arnulf Stenzl, Harriet C. Thoeny, J. Alfred Witjes - The Lancet 2022 cited by 434
- Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Authors: Andrew J. Armstrong, Arun Azad, Taro Iguchi, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers, Antonio Alcaraz, B. Yа. Alekseev, Neal D. Shore, F. Gómez-Veiga, Brad Rosbrook, Fabian Zohren, Shunsuke Yamada, Gabriel P. Haas, Arnulf Stenzl - Journal of Clinical Oncology 2022 cited by 299
- Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
Authors: Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti, Elena Castro, Tanya B. Dorff, Adam Stirling, Arnulf Stenzl, Mark T. Fleming, Celestia S. Higano, Fred Saad, Consuelo Buttigliero, Inge M. van Oort, Alexander Laird, Marielena Mata, Hsiang-Chun Chen, Cynthia G. Healy, Akos Czibere, Karim Fizazi - The Lancet Oncology 2021 cited by 277
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Authors: Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze‐Seemann, F. vom Dorp, Giorgio Parmiani, Christian Hampel, Steffen Wedel, Lutz Trojan, D. Jocham, Tobias Maurer, Gerd Rippin, Mariola Fotin‐Mleczek, Florian von der Mülbe, Jochen Probst, Ingmar Hoerr, Karl‐Josef Kallen, Thomas Lander, Arnulf Stenzl - Journal for ImmunoTherapy of Cancer 2015 cited by 284
- Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
Authors: Kenrick Ng, Arnulf Stenzl, Anand Sharma, Nikhil Vasdev - Urologic Oncology Seminars and Original Investigations 2020 cited by 215
- The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Authors: Robert S. Svatek, Brent K. Hollenbeck, Sten Holmäng, Richard Lee, Simon P. Kim, Arnulf Stenzl, Yair Lotan - European Urology 2014 cited by 571
- Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer
Authors: Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen, Stéphane Oudard, Paweł Wiechno, Bożena Kukiełka-Budny, Vladimír Šámal, Jaroslav Hájek, Susan Feyerabend, Vincent Khoo, Arnulf Stenzl, Tibor Csőszi, Zoran Filipovic, Frederico Gonçalves, А А Прохоров, Eric Cheung, Arif Hussain, Nuno Sousa, Amit Bahl, Syed A. Hussain, Harald Fricke, Pavla Kadlecová, Tomáš Scheiner, Roman Korolkiewicz, Jiřina Bartůňková, Radek Špíšek, VIABLE Investigators, Walter M. Stadler, Arthur Berg, Karl‐Heinz Kurth, Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C.M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg and 83 more - JAMA Oncology 2022 cited by 90
- Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021
Authors: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, James W.F. Catto, James N’Dow, Jens Sønksen, Arnulf Stenzl, Manfred Wirth - European Urology 2021 cited by 220
- Prevention and early detection of prostate cancer
Authors: Jack Cuzick, Mangesh A. Thorat, Gerald L. Andriole, Otis W. Brawley, Powel H. Brown, Zoran Čulig, Rosalind A. Eeles, Leslie G. Ford, Freddie C. Hamdy, Lars Holmberg, Dragan Ilić, Timothy J. Key, Carlo La Vecchia, Hans Lilja, Michael Marberger, Frank L. Meyskens, Lori M. Minasian, Chris Parker, Howard L. Parnes, Sven Perner, Harry G. Rittenhouse, Jack A. Schalken, Hans Peter Schmid, Bernd J. Schmitz‐Dräger, Fritz H. Schröder, Arnulf Stenzl, Bertrand Tombal, Timothy J Wilt, Alicja Wolk - The Lancet Oncology 2014 cited by 492
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Authors: Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, A Płużańska, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Regina Mendrzyk, Norbert Hilf, Oliver Schoor, Jens Fritsche, Andrea Mahr, Dominik Maurer, Verona Vass, Claudia Trautwein, Peter Lewandrowski, Christian Flohr, Heike Pohla, Janusz J Stańczak, Vincenzo Bronte, Susanna Mandruzzato, Tilo Biedermann, Graham Pawelec, Evelyna Derhovanessian, Hisakazu Yamagishi, Tsuneharu Miki, Fumiya Hongo, Natsuki Takaha, Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanović, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, Hans-Georg Rammensee, Carsten Reinhardt, Harpreet Singh‐Jasuja - Nature Medicine 2012 cited by 784
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Authors: Jürgen E. Gschwend, Matthias Heck, Jan Lehmann, H. Rübben, Peter Albers, J.M. Wolff, D. Frohneberg, Patrick de Geeter, Axel Heidenreich, T. Kälble, Michael Stöckle, Thomas Schnöller, Arnulf Stenzl, Markus Müller, Michael C. Truß, Stephan Roth, Uwe-Bernd Liehr, J. Leißner, Thomas Bregenzer, Margitta Retz - European Urology 2018 cited by 337
- Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
Authors: Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg, Sylvestre Le Moulec, Stéphane Oudard, Ugo De Giorgi, Michael Krainer, Andries M. Bergman, Wolfgang Hoelzer, Ronald de Wit, Martin Bögemann, Fred Saad, Giorgio Cruciani, Antoine Thiery-Vuillemin, Susan Feyerabend, Kurt Miller, Nadine Houédé, Syed A. Hussain, Elaine T. Lam, Jonathan Polikoff, Arnulf Stenzl, Paul N. Mainwaring, David A. Ramies, Colin Hessel, Aaron Weitzman, Karim Fizazi - Journal of Clinical Oncology 2016 cited by 247
- Economic aspects of bladder cancer: what are the benefits and costs?
Authors: K.D. Sievert, Bastian Amend, Udo Nagele, David Schilling, Jens Bedke, Marcus Horstmann, Jörg Hennenlotter, Stephan Kruck, Arnulf Stenzl - World Journal of Urology 2009 cited by 492
- A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
Authors: Omar Fahmy, Mohd Ghani Khairul‐Asri, Tina Schubert, M. Renninger, Rohan Malek, Hubert Kübler, Arnulf Stenzl, Georgios Gakis - Urologic Oncology Seminars and Original Investigations 2017 cited by 184
- Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Authors: Gillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, Werner J. Struss, Amanda Wong, Kevin Beja, Elie Ritch, Sonal Brahmbhatt, Stanislav Volik, Jörg Hennenlotter, Matti Nykter, Kim N., Scott North, Arnulf Stenzl, Colin C. Collins, Bernhard J. Eigl, Peter C. Black, Alexander W. Wyatt - Clinical Cancer Research 2017 cited by 164
- mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Authors: Steffen Rausch, Christian Schwentner, Arnulf Stenzl, Jens Bedke - Human Vaccines & Immunotherapeutics 2014 cited by 114
- IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
Authors: Brian I. Rini, Arnulf Stenzl, Romauld Zdrojowy, М. И. Коган, Mikhail Shkolnik, Stéphane Oudard, Steffen Weikert, Sergio Bracarda, Simon J. Crabb, Jens Bedke, Joerg Ludwig, Dominik Maurer, Regina Mendrzyk, Claudia Wagner, Andrea Mahr, Jens Fritsche, Toni Weinschenk, Steffen Walter, Alexandra Kirner, Harpreet Singh‐Jasuja, Carsten Reinhardt, Tim Eisen - The Lancet Oncology 2016 cited by 216
- TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
Authors: Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, Lena Mühlenbruch, Sarah M. Schroeder, Marian C. Neidert, Jonas Scheid, Steffen Lemke, Marissa L. Dubbelaar, Marcel Wacker, Anna Dengler, Reinhild Klein, Paul‐Stefan Mauz, Hubert Löwenheim, Mathias Hauri‐Hohl, Roland Martinꝉ, Jörg Hennenlotter, Arnulf Stenzl, Jonas S. Heitmann, Helmut R. Salih, Hans‐Georg Rammensee, Juliane S. Walz - Nature Communications 2023 cited by 46
- Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Authors: Robert J. Motzer, Naomi B. Haas, Frede Donskov, Marine Gross‐Goupil, Sergei Varlamov, Evgeny Kopyltsov, Jae‐Lyun Lee, Bohuslav Melichar, Brian I. Rini, Toni K. Choueiri, Milada Zemanová, Lori Wood, M. Neil Reaume, Arnulf Stenzl, Simon Chowdhury, Ho Yeong Lim, Ray McDermott, Agnieszka Michael, Weichao Bao, Marlene J. Carrasco-Alfonso, Paola Aimone, Maurizio Voi, Christian Doehn, Paul Russo, Cora N. Sternberg, on behalf of the PROTECT investigators - Journal of Clinical Oncology 2017 cited by 387
- Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
Authors: Luis A. Kluth, Peter C. Black, Bernard H. Bochner, James W.F. Catto, Seth P. Lerner, Arnulf Stenzl, Richard Sylvester, Andrew J. Vickers, Évanguelos Xylinas, Shahrokh F. Shariat - European Urology 2015 cited by 278
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
Authors: Susanne M. Rittig, Maik Haentschel, Katrin J Weimer, Annkristin Heine, Martin Müller, Wolfram Brugger, Marius Horger, Olga Maksimovic, Arnulf Stenzl, Ingmar Hoerr, Hans‐Georg Rammensee, Tobias A.W. Holderried, Lothar Kanz, Steve Pascolo, Peter Brossart - Molecular Therapy 2010 cited by 219
- EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
Authors: Stefano Fanti, Alberto Briganti, Louise Emmett, Karim Fizazi, Silke Gillessen, Karolien Goffin, Boris Hadaschik, Ken Herrmann, Jolanta Kunikowska, Tobias Maurer, Steven MacLennan, Nicolas Mottet, Declan G. Murphy, Daniela E. Oprea‐Lager, Joe M. O’Sullivan, Wim J.G. Oyen, Olivier Rouvière, Oliver Sartor, Arnulf Stenzl, Hendrik Van Poppel, Jochen Walz, Wim P.J. Witjes, Anders Bjartell - European Urology Oncology 2022 cited by 40
- Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Authors: Maximilian Burger, H. Barton Grossman, Michael J. Droller, Joerg Schmidbauer, Gregers G. Hermann, Octavian Drăgoescu, Eleanor Ray, Yves Fradet, Alexander Karl, J.P. Burgués, J. Alfred Witjes, Arnulf Stenzl, Patrice Jichlinski, D. Jocham - European Urology 2013 cited by 450
